3D Expanded Pluripotent Structures for In Vitro Embryogenesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge of studying human embryo development in vitro is hindered by the scarcity of surplus embryos and ethical restrictions, limiting understanding of critical developmental stages such as blastocyst formation and gastrulation.
Innovation Solution
A method involving pluripotent stem cells cultured in a specific media composition with TGFβ ligand, WNT agonist, and ROCK inhibitor, forming an expanded pluripotent stem cell structure that self-organizes into a three-dimensional EP structure, which can then be further reorganized to mimic early embryonic compartments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of information
If surplus human embryos are used for research, then understanding of embryonic development can be improved, but ethical and legal restrictions limit availability
Solution Approach 1:
The patent creates in vitro models that copy and replicate human embryonic development stages using pluripotent stem cells. These stem cell-derived structures mimic the morphology, gene expression, and protein expression of actual human embryos at various stages, providing a research model that eliminates the need for surplus embryos while maintaining scientific validity
Solution Approach 2:
The patent changes the fundamental parameter of the research model from using actual human embryos to using pluripotent stem cells under controlled in vitro conditions. This parameter change allows unlimited availability of the model system while maintaining the ability to study embryonic development processes
2Ease of operation
If in vitro culture methods are used, then study of embryo development is enabled, but critical developmental stages remain poorly understood
Solution Approach 1:
The patent segments the complex process of embryonic development into distinct stages that can be studied independently. By generating stem cell-derived structures at specific stages (morula-like, blastocyst-like, post-implantation), the method allows researchers to examine each developmental stage separately and understand the critical transitions between them
Solution Approach 2:
The patent moves from studying two-dimensional cell cultures to three-dimensional stem cell-derived structures that recapitulate the spatial organization and morphology of actual embryos. This dimensional transition enables more accurate modeling of developmental processes while maintaining in vitro controllability
3Quantity of substance
If pluripotent stem cells are cultured in 2D, then cell expansion is achieved, but three-dimensional structure formation is limited
Solution Approach 1:
The patent employs dynamic culture conditions that transition from 2D expansion to 3D structure formation. The method uses defined media compositions and signaling molecules to guide stem cells through morphogenetic transitions, allowing the system to adapt its spatial organization from monolayer cultures to three-dimensional embryonic-like structures
4Reliability
If defined media composition is used, then reproducibility is improved, but complexity of media formulation increases
Solution Approach 1:
The patent systematically defines and optimizes multiple parameters of the media composition, including concentrations of growth factors (BMP4, FGF2, WNT3A), inhibitors (ROCK inhibitor, ALK5 inhibitor), and basal media components. This comprehensive parameter definition ensures reproducibility across experiments while providing a complete, ready-to-use media formulation
Data Source
AI summary
Disclosed herein include methods and compositions for in vitro culture of three-dimensional expanded pluripotency (EP) structures from pluripotent stem cells. In some embodiments, the method can include generating expanded pluripotent stem cells (EPSCs) and culturing the EPSCs in a composition capable of supporting generation of the EP structure.